Switzer, C H <br/><br/>
Targeting SET/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy.  [electronic resource] 

 -  Oncogene  Jun 2011 
 - 2504-13 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2010.622  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>DNA-Binding Proteins<br/>Histone Chaperones--antagonists & inhibitors<br/>Humans<br/>NM23 Nucleoside Diphosphate Kinases--metabolism<br/>Neoplasms--drug therapy<br/>Peptides--therapeutic use<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Transcription Factors--antagonists & inhibitors<br/>rac1 GTP-Binding Protein--metabolism